MD-300

N/A

Report date: 2024/04/10 13:52:16
NME

Base Information

Drug NameMD-300
Drug Alias NameMD-300MD300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 1 inhibitorsMitogen-activated protein kinase kinase kinase 11 inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 1Mitogen-activated protein kinase kinase kinase 11
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMD Biolab Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMD Biolab Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A